Bimatoprost: all 87 studies that test it

Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular HypertensionRecruitingNCT07661329Phase 3
• A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both EyesRecruitingNCT06267274Phase 1
• Treatment of Hypopigmented Scars With BimatoprostRecruitingNCT06122090Phase 2
• A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT04285580Phase 3Results posted
• Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous PatientsCompletedNCT03825380Phase 3Results posted
• Topical Bimatoprost for Chemical BlepharoplastyCompletedNCT02830776Early Phase 1Results posted
• A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular HypertensionCompletedNCT02742649Phase 1/2Results posted
• A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT02636946Phase 3Results posted
• An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular InsertCompletedNCT02537015Phase 2Results posted
• Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT02507687Phase 3Results posted
• Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye PressureCompletedNCT02448043Not applicableResults posted
• Stop Retinal Ganglion Cell Dysfunction StudyTerminatedNCT02390284Phase 3Results posted
• Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT02250651Phase 3Results posted
• Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular HypertensionCompletedNCT02247804Phase 3Results posted
• Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)CompletedNCT02176356Phase 4Results posted
• Topical Bimatoprost Effect on Androgen Dependent Hair FolliclesCompletedNCT02170662Phase 2Results posted
• An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 ProductCompletedNCT02143843Phase 2Results posted
• Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular HypertensionCompletedNCT02097719Phase 4Results posted
• A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular HypertensionCompletedNCT02061683Phase 4Results posted
• A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular HypertensionCompletedNCT02020512Phase 4Results posted
• Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT01915940Phase 2Results posted
• An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular HypertensionCompletedNCT01881126Phase 4Results posted
• A Study of LUMIGAN® RC in the Clinical SettingCompletedNCT01833741Phase 4Results posted
• A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular HypertensionCompletedNCT01830140Phase 3Results posted
• Bimatoprost for the Treatment of Eyebrow HypotrichosisCompletedNCT01765764Phase 3Results posted
• A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)CompletedNCT01594970Phase 4Results posted
• Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) ReductionCompletedNCT01547598Phase 4Results posted
• Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)CompletedNCT01464424Phase 4Results posted
• Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash ProminenceCompletedNCT01448525Phase 4Results posted
• Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash HypotrichosisCompletedNCT01391286Phase 3Results posted
• Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash HypotrichosisCompletedNCT01391273Phase 3Results posted
• Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT01298700Phase 4Results posted
• Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01291108Phase 2Results posted
• 24-hour IOP-lowering Effect of 0.01% BimatoprostCompletedNCT01271686Phase 4Results posted
• Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01253902Phase 4Results posted
• Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been TreatedCompletedNCT01243567Phase 4Results posted
• Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01241240Phase 3Results posted
• Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean SubjectsCompletedNCT01229423Phase 4Results posted
• Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01217606Phase 3Results posted
• Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®CompletedNCT01170884Phase 4Results posted
• Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular HypertensionCompletedNCT01157364Phase 1/2Results posted
• Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT01099774Phase 3Results posted
• Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01068964Not applicableResults posted
• Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash ProminenceCompletedNCT01064882Phase 2Results posted
• Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in ChildrenCompletedNCT01023841Phase 4Results posted
• Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash HypotrichosisCompletedNCT00958035Phase 4Results posted
• Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid MarginCompletedNCT00907426Phase 3Results posted
• Eyelash Growth From Application of Bimatoprost in Gel Suspension to the Base of the EyelashesCompletedNCT00773136Not applicableResults posted
• The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the EyeCompletedNCT00705757Phase 4Results posted
• Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash ProminenceCompletedNCT00693420Phase 3Results posted
• Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular HypertensionCompletedNCT00541242Phase 4Results posted
• Evaluation of Hyperemia With the Use of Ocular Prostaglandin AnaloguesCompletedNCT00539526Phase 4Results posted
• A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular HypertensionCompletedNCT00538304Phase 2Results posted
• Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%CompletedNCT00440011Phase 4Results posted
• Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia AreataCompletedNCT05600673Phase 1/2
• Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension GlaucomaStatus unknownNCT04981886Phase 4
• Effect of Microneedling, Bimatoprost and Excimer in Vitiligo TreatmentCompletedNCT04738149Early Phase 1
• Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle GlaucomaCompletedNCT03966560Phase 4
• Long-term Safety and Efficacy Extension Trial of Bimatoprost SRCompletedNCT03891446Phase 3
• Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT03850782Phase 3
• Bimatoprost 0.03% Solution With NB-UVB Versus Their Use With Fractional Carbon Dioxide Laser in Treatment of Generalized VitiligoStatus unknownNCT03487042Phase 4
• Topical Bimatoprost in the Treatment of MigraineStatus unknownNCT03419715Phase 2
• Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)CompletedNCT02863705Phase 4
• Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic AlopeciaCompletedNCT02848300Phase 1
• Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)TerminatedNCT02676310Phase 1
• Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular HypertensionCompletedNCT02571712Phase 4
• Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin AnaloguesCompletedNCT02155049Phase 3
• Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion PressuresCompletedNCT02154217Phase 3
• Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)CompletedNCT02059655Phase 4
• Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning EyebrowsCompletedNCT01891487Phase 4
• 24-hour Control of Intraocular Pressure (IOP) in Ocular HypertensionCompletedNCT01655758Phase 4
• Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus PlaceboCompletedNCT01387906Phase 4
• Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant GlaucomaStatus unknownNCT01361841Not applicable
• Topical Bimatoprost Solution 0.03%in Stable VitiligoWithdrawnNCT01202513Phase 4
• Study of Bimatoprost Gel on Eyelash GrowthCompletedNCT01200251Phase 3
• Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy ParticipantsWithdrawnNCT00999557Not applicable
• Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed CombinationCompletedNCT00941096Phase 4
• Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the USCompletedNCT00847483Phase 4
• Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular HypertensionCompletedNCT00652496Phase 2
• Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00651859Phase 2
• Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.CompletedNCT00355446Phase 4
• A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular HypertensionCompletedNCT00348062Phase 4
• Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular HypertensionCompletedNCT00348023Phase 4
• Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to LatanoprostCompletedNCT00347841Phase 4
• Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%CompletedNCT00347802Phase 4
• Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular HypertensionCompletedNCT00300443Phase 2/3
• Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia AreataCompletedNCT00187577Not applicable

← Bimatoprost overview